TY  - JOUR
AU  - Ruiz-Llobet, Anna
AU  - Gassiot, Susanna
AU  - Sarrate, Edurne
AU  - Zubicaray, Josune
AU  - Dapena, José Luis
AU  - Rives, Susana
AU  - Sevilla, Julián
AU  - Menárguez López, Ángela
AU  - Panesso Romero, Melissa
AU  - Montoya, Catalina
AU  - Vagace, José Manuel
AU  - Molina Hurtado, José Ramón
AU  - García-Morín, Marina
AU  - García Abós, Miriam
AU  - Mendoza Sánchez, María Carmen
AU  - Lendínez, Francisco
AU  - Palomo Moraleda, Pilar
AU  - Tallón, María
AU  - González, Berta
AU  - Urrutia, Emilia
AU  - Serna, José Vicente
AU  - Peláez Pleguezuelos, Irene
AU  - Martínez Merino, Marta
AU  - Ramos Elbal, Eduardo
AU  - Orellana, Elena
AU  - Benítez Muñoz, Helga
AU  - Berrueco, Rubén
PY  - 2022
DO  - 10.1111/jth.15699
UR  - http://hdl.handle.net/10668/20003
T2  - Journal of thrombosis and haemostasis : JTH
AB  - Symptomatic venous thromboembolism (VTE) is diagnosed in 3%-14% of patients during pediatric acute lymphoblastic leukemia (ALL) therapy. There are well-known risk factors, but the role of others as inherited thrombophilia is still controversial....
LA  - en
KW  - acute lymphoblastic leukemia
KW  - children
KW  - prophylaxis
KW  - thrombophilia
KW  - thrombosis
KW  - Anticoagulants
KW  - Child
KW  - Heparin, Low-Molecular-Weight
KW  - Humans
KW  - Precursor Cell Lymphoblastic Leukemia-Lymphoma
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Thrombophilia
KW  - Venous Thromboembolism
TI  - Venous thromboembolism in pediatric patients with acute lymphoblastic leukemia under chemotherapy treatment. Risk factors and usefulness of thromboprophylaxis. Results of LAL-SEHOP-PETHEMA-2013.
TY  - research article
VL  - 20
ER  -